Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (NCT07304024) titled 'A Treatment for a Form of Age-Related Central Auditory Processing Disorder Consisting of Clemastine Fumarate Plus Engineered Sound' on Dec. 19, 2025.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
Primary Sponsor: University of Colorado, Denver
Condition:
Central Auditory Processing Disorder
Hearing Impaired (Partially)
Hearing
Hearing Abnormality
Hearing Disability
Hearing Disorder
Hearing Disorders
Hearing Impairment, Sensorineural
Hearing Handi...